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Abstract
The plant Withania somnifera (Linn.) (Solanacea) is a well-known herbal medicine used in many 
parts of the world.  It has anti-inflammatory, antioxidant, and antitumor as well as neural protective 
properties.  It seems as if the two most active withanolide components, namely withaferin A and 
withanolide D, found in methanol (MeOH) extracts, are responsible for the anti-inflammatory and 
antioxidant properties of the plant.  The current research evaluated and compared the cytotoxic potential 
of water and methanol extracts of W. somnifera using a combined crystal violet MTT and Neutral Red 
assay.  MRC-5 cells, a human embryonic lung-derived diploid fibroblast cell line, were the cells of choice.
We found that the three lowest concentrations (0.007, 0.042, 0.250 µg/ml) of the plant material extracted 
in double distilled H2O and MeOH do not differ significantly in any of the assays.  We therefore suggest 
that low concentrations of MeOH extracts (up to 0.250 µg/ml plant material) do not cause cell damage to 
the MRC-5 cells, however, higher levels should be avoided as cell viability and cell numbers are 
negatively influenced. 
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Introduction
Withania somnifera (Linn.) is a member of the plant family Solanaceae and is also known as 
Ashwagandha, Indian Ginseng or Winter Cherry. It is an important component of the Ayurvedic 
pharmacopoeia of India, where it has been used for hundreds of years (Henderson and Anderson, 1966; 
Ahmad et al., 2005; Glaser, 1988). It has a wide distribution in Africa, Southern Europe and Asia, and is 
considered to be indigenous to South Africa (Henderson and Anderson, 1966). It also grows in the drier 
tropical regions and is also found from Liberia to Nigeria and the Southeast Islands (Iwu, 1993).
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The plant is chemically very complex and more than 80 compounds have been isolated (van Wyk 
et al., 2000). The withanolides (steroids with an ergostane skeleton), particularly Withaferin A, 3-β-
hydroxy-2,3-dihydrowithanolide F as well as Withanolide D are of particular medicinal interest (Chu et al., 
1988; van Wyk et al., 2000). Research has shown that W. somnifera has anti-inflammatory, antioxidant
anti-tumour and immunomodulatory properties (Anbalagan and Sadique, 1981; Begum and Sadique, 
1988; Somasundaram et al., 1983; Kulkarni et al., 1991; Al-Hindawi et al., 1992; Begum and Sadique,
1987; Bhattacharya et al., 1997; Parihar and Hemnani, 2003; Parihar et al., 2004).  
Some of the important active compounds reported in the herb include the following: Withaferin A, 
sitoindosides VII-X, 5-dehydroxywithanolide-R, Withasomniferin-A, 1-oxo-5beta,6beta-epoxy-witha-2-
ene-27-ethoxy-olide,4-(1-hydroxy-2,2-methylcyclpropanone) -2,3-dihydrowithaferin A, 2,3-
dihydrowithaferin A, 24,25-dihydro-27-desoxywithaferin A, physagulin D (1-6)-beta-D-glucopyranosyl-(1-
4)-beta-D-glucopyranoside, 27-O-beta-D-glucopyranosylphysagulin D, physagulin D, Withanoside I-VII, 
27-O-beta-D-glucopyranosylviscosalactone B, 4,16-dihydroxy-beta,6beta-epoxyphysagulin D, 
Viscosalactone B and Diacetylwithaferin A (Uma Devi, 1996; Ganzera et al., 2003; Jayaprakasam et al., 
2003., Kaur et al., 2003; Matsuda et al., 2001).  
The two most active Withanolide components, Withaferin A and Withanolide D are found in 
methanol extracts (Kuboyama et al., 2002; Ganzera et al., 2003; Choudhary et al., 2004). Also, the main 
antioxidant activity of W. somnifera was found in the methanol fraction (Parihar et al., 2004).  Although 
water extracts are also known to have great medicinal potential, the methanol extracts seem to extract 
the active components the best.  The question, however, arises whether the methanol extracts of the 
herb may be cytotoxic to cells in culture.  Therefore, because of the potential use of the herb as an anti-
inflammatory product, the current research aimed to evaluate and compare the cytotoxic potential of 
water and methanol extracts of W. somnifera using a combined Crystal Violet assay, the MTT assay and 
the Neutral Red assay.  The cells of choice were MRC-5 cells, which is a human embryonic lung-derived 
diploid fibroblast cell line.  Statistical analyses were employed to determine whether there is a correlation 
between the two extract methods, as well as the concentrations used.
Experimental Procedures
Herb material
Root material (WS1PRETORIA) was collected in the Pretoria area (South Africa) and identified by 
botanists from the Department of Botany, University of Pretoria, South Africa. A herbarium specimen was 
prepared and compared to an authentic specimen in the HGJW Sweikerdt herbarium at the University of 
Pretoria.
Preparation of extracts
Leaves, stems and roots were fragmented and dried at 45ºC for 48 h and MeOH and water 
extracts were made. Plant material (140 mg) was added to 1,400 ml double distilled (dd) H2O of water, 
yielding a final concentration of 100mg plant material per ml.  2.1039 g of MeOH extracted plant material 
was added to 4.2 ml MeOH, yielding a final concentration of 0.5 g of plant material per ml MeOH.  This 
was diluted 1:4 with dd H2O, yielding a final concentration of 100 mg plant material in 1 ml.  Five 
concentrations of extracts of both ddH2O and MeOH were added to the cells in culture. The 
concentrations were: 0.007, 0.042, 0.250, 1.151, and 9.090 µg/ml.
MRC-5 Permanent cell line
MRC-5 cells were obtained from Highveld Biological Company, Johannesburg, South Africa. The 
cells were plated at a cell concentration of 2x104 cells per ml in 24 flat well plates and were kept for 24 h 
at 37C and 5% CO2 before conducting the experiments. Solution of 100mg/ml of each of the plant 
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extracts was prepared either in dd H2O or MeOH and exposed to MRC-5 cells for 48 h.  The cytotoxicity 
of MeOH alone was also determined.
Combined Crystal Violet, MTT and Neutral Red assay
Cell number, cell viability and lysosomal membrane integrity, were determined using a combined 
Crystal Violet, MTT and Neutral Red (CV/MTT/NR) assay.  To each well 100μl 0.15% NR prepared in
DPBS (A 10x DPBS stock solution was prepared by dissolving 2g/l KCl, 2g KH2PO4, 80g/l NaCl 
and Na2HPO4 in ddH2O that was diluted 1:9 with ddH2O prior to use) was added and then incubated for 
90 min at 37°C in a CO2 incubator. A further 50l volume of a 0.1 mg/ml 3-(4,5- Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) solution prepared in DPBS was added to each well and the cell 
culture plates were maintained for a further 60 min at 37°C. The medium was then carefully removed and 
the plates were blotted dry. The cells were fixed for 10 min with 200µl of a 1% acetic acid and 1% 
formaldehyde solution in ddH2O. The fixative was removed and the NR was solubilized with 200µl of a 
1% acetic acid and 50% ethanol solution prepared in ddH2O. The dissolved NR was transferred into a 
96-flat well plate. The MTT formazan crystals were then dissolved with 200l DMSO by shaking of the 
plates for 20 min before being transferred into a 96-flat well plate. Each well was washed once with 
DPBS and was dried in a microwave oven for a few mins at 60% power. The cells attached to the bottom 
of the plate were stained by adding a volume of 300µl of a 0.1% (weight/ volume (w/v) CV solution 
prepared in 200mM of formic acid pH 3.5, each well for 60 min. After the microplate was washed with 
ddH2O and dried, the bound dye was dissolved in 10% acetic acid prepared in ddH2O. The solution was 
transferred to a 96-well and the absorbance of all bioassays was determined spectrophotometrically at 
570 nm using the Microplate Reader (ELx800).
Statistical analysis
The experiment was conducted in a factorial design with main effects the extracts at two levels 
(plant material extracted in ddH2O and also in MeOH) and concentration at five levels (0.007, 0.042,
0.250, 1.151, and 9.090 µg/ml).  For each of the three assays the outcome variable was analysed in an 
appropriate analysis of variance (ANOVA) with two fixed effects, namely extract and concentration as 
well as the interaction.  Pair-wise comparisons were done using the LSD method of Fisher.  Testing was 
done at the 0.05 level of significance. 
Results and Discussion
Combined Crystal Violet, MTT and Neutral Red assay
The CV assay measures cell number in the presence of the 5 concentrations of the two extracts.  
All analyses were performed on the dataset and bar graphs of the results compiled (Figure 1 – 3).  From 
the ANOVA the two extracts differ significantly (p = 0.109) but not the concentrations (p = 0.5676). 
However, a significant interaction between extracts and concentrations exists (p<0.0001).  This 
interaction is displayed in Figure 1.  Note that the first 3 concentrations of the two extracts react similarly 
but behave very differently over the last two concentrations, causing the significant difference between 
extracts (p = 0.0109) at these high concentrations, the ddH2O extract increased cell numbers, while the 
MeOH extract caused a decrease.
Figure 2 displays the results of the MTT assay, showing cell viability.  ANOVA showed that the 
two extracts differ significantly (p = 0.0005) and that the concentrations also differ significantly (p<
0.0001). In particular, following pair wise comparisons, the first three concentrations do not differ 
significantly but differ from the last two concentrations which also differ from each other.  There is also a 
significant interaction between extract and concentration (p = 0.0110) which is clear from Figure 2, where 
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except for the fourth concentration the extracts behave similarly.  However, what can be concluded from 
the graph is that cell viability decreases when using the two highest concentrations of the MeOH extract 
and the highest concentration of the ddH2O extract. 
Crystal Violet Assay
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Figure 1: Effects of 5 concentrations of W. somnifera, extracted in ddH2O and MeOH and prepared in 
cell culture medium on MRC-5 cell number after 48 h exposure: results from Crystal Violet 
Assay. 
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Figure 2: Effects of 5 concentrations of W. somnifera, extracted in ddH2O and MeOH and
                prepared in cell culture medium on MRC-5 cell viability after 48 h exposure: results from 
                MTT Assay.
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Neutral Red Assay
0
20
40
60
80
100
120
140
0.007 0.042 0.25 1.51 9.09
Concentration (µg/ml)
%
 C
o
n
tr
o
l
water extract
MeOH extract
Figure 3: Effects of 5 concentrations of W. somnifera, extracted in ddH2O and MeOH and prepared in 
cell culture medium on MRC-5 lysosomal integrity after 48 h exposure: results from Neutral Red 
Assay.
The final assay, namely the NR assay, which determines lysosomal membrane integrity, is 
presented in Figure 3.  ANOVA showed that respectively the extracts and the concentrations are 
significantly different (p = 0.0304 and p = 0.0170). In particular, LSD pair-wise comparisons show that the 
first four concentrations do not differ significantly; however, these four concentrations differ from the 
highest concentration.  The significant interaction between extract and concentration is also clear in 
Figure 3, where the two extracts behave similarly over the first three concentrations and quite differently 
over the last two concentrations.  
We therefore conclude that the three lowest concentrations (0.007, 0.042, and 0.250 µg/ml) of the 
of the plant material extracted in ddH2O and MeOH seems not to be significantly different in any of the 
assays.  At these three concentrations cell numbers, cell viability and lysosomal membrane activity were 
preserved.  
Thus low concentrations of MeOH extracts (up to 0.250 µg/ml plant material) do not cause cell 
damage to the human embryonic lung-derived diploid fibroblast cell line, however, higher levels should 
be avoided as particularly cell viability and cell numbers are negatively influenced. The two active 
components Withaferin A and Withanolide D are most successfully extracted using MeOH (Kuboyama et 
al., 2002; Ganzera et al., 2003; Choudhary et al., 2004).   Research therefore investigating the anti-
inflammatory or antioxidant activity of W. somnifera can use MeOH extracts, but care should be taken 
not to use concentrations that are too high. 
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